These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22565359)

  • 21. Cross-cultural development of the EORTC QLQ-SWB36: a stand-alone measure of spiritual wellbeing for palliative care patients with cancer.
    Vivat B; Young T; Efficace F; Sigurđadóttir V; Arraras JI; Åsgeirsdóttir GH; Brédart A; Costantini A; Kobayashi K; Singer S;
    Palliat Med; 2013 May; 27(5):457-69. PubMed ID: 22843128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary psychometric validation of the Polish version of the EORTC elderly module (QLQ-ELD14).
    Wrazen W; Golec EB; Tomaszewska IM; Walocha E; Dudkiewicz Z; Tomaszewski KA
    Folia Med Cracov; 2014; 54(2):35-45. PubMed ID: 25648308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.
    Arrieta Ó; Núñez-Valencia C; Reynoso-Erazo L; Alvarado S; Flores-Estrada D; Angulo LP; Oñate-Ocaña LF
    Lung Cancer; 2012 Jul; 77(1):205-11. PubMed ID: 22387006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care.
    Suárez-del-Real Y; Allende-Pérez S; Alférez-Mancera A; Rodríguez RB; Jiménez-Toxtle S; Mohar A; Oñate-Ocaña LF
    Psychooncology; 2011 Aug; 20(8):889-96. PubMed ID: 20662106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
    Chow E; Nguyen J; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bottomley A;
    Cancer; 2012 Mar; 118(5):1457-65. PubMed ID: 21837676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30?
    Hinz A; Einenkel J; Briest S; Stolzenburg JU; Papsdorf K; Singer S
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):677-83. PubMed ID: 22624663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer.
    Paradowski J; Tomaszewski KA; Bereza K; Tomaszewska IM; Pasternak A; Paradowska D; Szczęsny E; Golec EB; Greimel ER; Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):157-63. PubMed ID: 24354727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
    Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
    Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model.
    Shih CL; Chen CH; Sheu CF; Lang HC; Hsieh CL
    Value Health; 2013; 16(5):848-54. PubMed ID: 23947980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current developments in measuring quality of life with instruments of the European organisation for research and treatment of cancer (EORTC)].
    Singer S; Hofmeister D; Spiegel K; Boehm A
    Laryngorhinootologie; 2011 Oct; 90(10):591-4. PubMed ID: 22016255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma.
    Chmielowska K; Tomaszewski KA; Pogrzebielski A; Brandberg Y; Romanowska-Dixon B
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):88-96. PubMed ID: 22966840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.
    Winstanley JB; Young TE; Boyle FM; Bergenmar M; Bottomley A; Burmeister B; Campana LG; Garioch JJ; King M; Nikolic DV; van de Poll-Franse LV; Saw R; Thompson JF; White EG;
    Melanoma Res; 2015 Feb; 25(1):47-58. PubMed ID: 25325247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.
    Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M;
    Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries.
    Arraras JI; Kuljanic-Vlasic K; Bjordal K; Yun YH; Efficace F; Holzner B; Mills J; Greimel E; Krauss O; Velikova G;
    Psychooncology; 2007 Mar; 16(3):249-54. PubMed ID: 16858744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Mexican Spanish version of the EORTC QLQ-H&N35 instrument to measure health-related quality of life in patients with head and neck cancers.
    Carrillo JF; Ortiz-Toledo MA; Salido-Noriega Z; Romero-Ventura NB; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Ann Surg Oncol; 2013 May; 20(5):1417-26. PubMed ID: 23108555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development.
    Gamper EM; Groenvold M; Petersen MA; Young T; Costantini A; Aaronson N; Giesinger JM; Meraner V; Kemmler G; Holzner B;
    Psychooncology; 2014 Apr; 23(4):397-403. PubMed ID: 24217943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.